This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2010 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by:
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT01152593
First received: May 31, 2010
Last updated: June 28, 2010
Last verified: June 2010
May 31, 2010
June 28, 2010
July 2010
July 2014   (Final data collection date for primary outcome measure)
Reduction of the incidence of surgical site infections after cesarean section [ Time Frame: Four years ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections
Not Provided
The investigators believe that irradication of nose colonization of staphyloccocus aureus will reduce the incidence of surgical site infections after cesarean section.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
  • Surgical Wound Infection
  • Cesarean Section
  • Staphylococcus Aureus
Drug: Mupirocin
Intranasal cream given to patient after confirmation of colonization
Experimental: Intranasal Mupirocin
Intervention: Drug: Mupirocin
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
400
December 2014
July 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Women assigned to undergo cesarean section

Exclusion Criteria:

  • All others
Sexes Eligible for Study: Female
Child, Adult, Senior
Not Provided
Contact information is only displayed when the study is recruiting subjects
Israel
 
 
NCT01152593
HYMC0033-10
Not Provided
Not Provided
Not Provided
Gai Shrem, MD, Hillel Yaffe Medical Center
Hillel Yaffe Medical Center
Not Provided
Not Provided
Hillel Yaffe Medical Center
June 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP